<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Frorup C</submitter><funding>Steno Diabetes Center Copenhagen (SDCC)</funding><funding>Novo Nordisk Fonden</funding><pagination>744509</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8531745</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>12</volume><pubmed_abstract>Type 1 diabetes is an immune-driven disease, where the insulin-producing beta cells from the pancreatic islets of Langerhans becomes target of immune-mediated destruction. Several studies have highlighted the implication of circulating and exosomal microRNAs (miRNAs) in type 1 diabetes, underlining its biomarker value and novel therapeutic potential. Recently, we discovered that exosome-enriched extracellular vesicles carry altered levels of both known and novel miRNAs in breast milk from lactating mothers with type 1 diabetes. In this study, we aimed to characterize exosomal miRNAs in the circulation of lactating mothers with and without type 1 diabetes, hypothesizing that differences in type 1 diabetes risk in offspring from these groups are reflected in the circulating miRNA profile. We</pubmed_abstract><journal>Frontiers in immunology</journal><pubmed_title>Plasma Exosome-Enriched Extracellular Vesicles From Lactating Mothers With Type 1 Diabetes Contain Aberrant Levels of miRNAs During the Postpartum Period.</pubmed_title><pmcid>PMC8531745</pmcid><funding_grant_id>SDCC 3.D Type1 Biology</funding_grant_id><funding_grant_id>NNF14OC0009275</funding_grant_id><pubmed_authors>Engelbrekt C</pubmed_authors><pubmed_authors>Storling J</pubmed_authors><pubmed_authors>Johannesen J</pubmed_authors><pubmed_authors>Pociot F</pubmed_authors><pubmed_authors>Mathiesen ER</pubmed_authors><pubmed_authors>Kaur S</pubmed_authors><pubmed_authors>Frorup C</pubmed_authors><pubmed_authors>Yarani R</pubmed_authors><pubmed_authors>Nielsen LB</pubmed_authors><pubmed_authors>Svare J</pubmed_authors><pubmed_authors>Mortensen HB</pubmed_authors><pubmed_authors>Damm P</pubmed_authors><pubmed_authors>Mirza AH</pubmed_authors></additional><is_claimable>false</is_claimable><name>Plasma Exosome-Enriched Extracellular Vesicles From Lactating Mothers With Type 1 Diabetes Contain Aberrant Levels of miRNAs During the Postpartum Period.</name><description>Type 1 diabetes is an immune-driven disease, where the insulin-producing beta cells from the pancreatic islets of Langerhans becomes target of immune-mediated destruction. Several studies have highlighted the implication of circulating and exosomal microRNAs (miRNAs) in type 1 diabetes, underlining its biomarker value and novel therapeutic potential. Recently, we discovered that exosome-enriched extracellular vesicles carry altered levels of both known and novel miRNAs in breast milk from lactating mothers with type 1 diabetes. In this study, we aimed to characterize exosomal miRNAs in the circulation of lactating mothers with and without type 1 diabetes, hypothesizing that differences in type 1 diabetes risk in offspring from these groups are reflected in the circulating miRNA profile. We</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021</publication><modification>2026-05-09T03:45:20.872Z</modification><creation>2025-02-19T01:44:07.287Z</creation></dates><accession>S-EPMC8531745</accession><cross_references><pubmed>34691048</pubmed><doi>10.3389/fimmu.2021.744509</doi></cross_references></HashMap>